Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 13/October/2014, 11.58 am

Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 13/October/2014, 11.58 am

Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 13/October/2014, 11.58 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Natural product-based therapy for Hypertension: Fangchinoline, an anti-inflammatory and anti-cancerous compound isolated from Stephania, decreases renal oxidative stress and blood pressure via up regulation of its target gene, 13/October/2014, 11.58 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance:  It has been shown that accumulation of excessive renal reactive oxygen  species (ROS) raises blood pressure. This study suggests, for the first time, Fangchinoline, by increasing the expression of its target gene,  it may decrease the levels of ROS. Thereby, it may function as an antihypertensive agent. Thus, pharmacological formulations encompassing “Fangchinoline or its analogues” can be used to treat hypertension.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation